The price of Aurora Cannabis Inc (NASDAQ: ACB) closed at $3.26 in the last session, up 0.62% from day before closing price of $3.24. In other words, the price has increased by $+0.0200 from its previous closing price. On the day, 1323801 shares were traded. ACB stock price reached its highest trading level at $3.3400 during the session, while it also had its lowest trading level at $3.1200.
Ratios:
We take a closer look at ACB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 3.79. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 177.58M and an Enterprise Value of 144.05M. As of this moment, Aurora’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.36. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 0.40. Its current Enterprise Value per Revenue stands at 0.68 whereas that against EBITDA is -0.09.
Stock Price History:
Over the past 52 weeks, ACB has reached a high of $11.50, while it has fallen to a 52-week low of $3.16. The 50-Day Moving Average of the stock is 4.2755, while the 200-Day Moving Average is calculated to be 5.1038.
Shares Statistics:
According to the various share statistics, ACB traded on average about 712.83K shares per day over the past 3-months and 1.13M shares per day over the past 10 days. A total of 34.53M shares are outstanding, with a floating share count of 15.68M. Shares short for ACB as of Jan 31, 2024 were 3.62M with a Short Ratio of 5.07, compared to 3.59M on Dec 29, 2023.
Earnings Estimates
The company has 1 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.3 for the current quarter, with a high estimate of -$0.3 and a low estimate of -$0.3, while EPS last year was -$1.48. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.07 and -$1.63 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.33, with 4 analysts recommending between -$0.07 and -$0.73.
Revenue Estimates
According to 3 analysts, the current quarter’s revenue is expected to be $52.13M. It ranges from a high estimate of $54M to a low estimate of $51.16M. As of the current estimate, Aurora Cannabis Inc’s year-ago sales were $46.86M, an estimated increase of 11.20% from the year-ago figure.
Based on 4 analysts’ estimates, the company’s revenue will be $237.85M in the next fiscal year. The high estimate is $250.59M and the low estimate is $225.16M. The average revenue growth estimate for next year is up 18.60% from the average revenue estimate for this year.
